Federal award
MAPP BIOPHARMACEUTICAL, INC.
HDTRA113C0018
Contract
Obligated and Ceiling
- Obligated (net)
- $11,174,406.12
- Ceiling (potential value, not spending)
- $12,566,308.00
- Current value
- $11,438,073.00
- Gross positive obligations
- $11,450,661.29
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- MAPP BIOPHARMACEUTICAL, INC. · M9V9QTHR1H28
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- MAPP BIOPHARMACEUTICAL, INC. · M9V9QTHR1H28
- Awarding agency
- Department of War · sub-agency 9761 · office HDTRA1
- Funding agency
- Department of War · sub-agency 9761
- Product or service (PSC)
- AN12 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
- Industry (NAICS)
- 541711 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
- PIID
- HDTRA113C0018
- Award type code
- D
- Actions
- 11 · Feb 19, 2013 to Dec 6, 2021
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History11
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Dec 6, 2021 | FY2022 | P00007 | C | $12,588.29 | — |
| Apr 20, 2021 | FY2021 | ARZ996 | M | $0.00 | — |
| Sep 27, 2019 | FY2019 | P00006 | B | −$228,724.81 | — |
| Aug 8, 2018 | FY2018 | A00001 | C | −$47,530.36 | — |
| Aug 28, 2015 | FY2015 | P00005 | B | $2,369,434.00 | — |
| Apr 17, 2015 | FY2015 | P00004 | B | $0.00 | — |
| Dec 4, 2014 | FY2015 | PZ0001 | L | $905,335.00 | — |
| Jul 28, 2014 | FY2014 | P00003 | A | $2,967,936.00 | — |
| Feb 20, 2014 | FY2014 | P00002 | G | $2,864,542.00 | — |
| Jul 24, 2013 | FY2013 | P00001 | B | $583,690.50 | — |
| Feb 19, 2013 | FY2013 | 0 | — | $1,747,135.50 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.